SCHEMBL3333810

SCHEMBL3333810

Clc1ccc(-c2nc3ccccc3[nH]2)cc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 13/20 0.61
RAB9A P51151 13/20 0.61
GAA P10253 1/20 0.61
KDM4E B2RXH2 11/20 0.60
ALDH1A1 P00352 11/20 0.60
SMN1; SMN2 Q16637 10/20 0.59
POLB P06746 2/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
HPGD P15428 5/20 0.58
HSD17B10 Q99714 4/20 0.58
MAPT P10636 4/20 0.58
TP53 P04637 3/20 0.58
GFER P55789 1/20 0.58
GPR55 Q9Y2T6 1/20 0.58
PKM P14618 5/20 0.58
ABCB11 O95342 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
NFKB1 P19838 1/20 0.57
NFKB2 Q00653 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7395745 0.86 NPC1 (0.56) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL2248705 0.86 NPC1 (0.69) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL5636118 0.85 CHEK2 (0.63) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL2278458 0.83 KMO (0.53) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL28117058 0.82 NPC1 (0.69) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL13406021 0.82 ALDH1A1 (0.50) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL17255270 0.82 NPC1 (0.47) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL29386825 0.82 NPC1 (0.88) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL2178266 0.82 NPC1 (0.88) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL11341763 0.81 KDM4E (0.55) NPC1RAB9AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433929-B Organic solderability copper surface protective agent and preparation method thereof 深圳市豪龙新材料技术有限公司 2023-08-08 CN claimed
CN-115433929-A Organic weldable copper surface protective agent and preparation method thereof 深圳市豪龙新材料技术有限公司 2022-12-06 CN claimed
CN-115433929-B Organic solderability copper surface protective agent and preparation method thereof 深圳市豪龙新材料技术有限公司 2023-08-08 CN disclosed
CN-115433929-A Organic weldable copper surface protective agent and preparation method thereof 深圳市豪龙新材料技术有限公司 2022-12-06 CN disclosed
US-8198307-B2 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2012-06-12 US disclosed
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-10 US disclosed
WO-2008140239-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-11-20 WO disclosed
US-3953600-A HYPOLIPIDEMIC AGENTS SANDOZ, INC. (US) 1976-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME TYR, MCHR1, MCHR2 NPC1 223/4885RAB9A 687/4885GAA 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.